Weight Loss Drugs (BK2152) Stock Price, News, Quotes

Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

1488.221
-12.755-0.85%

Trading Apr 28 14:33 ET

1505.856High1482.086Low

Constituent Stocks: 7Top Rising: GPCR+1.39%

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Constituent Stocks

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

GPCRStructure Therapeutics

24.0700.330+1.39%223.44K5.40M23.74023.74024.56523.7101.38B1.20B57.54M49.85M+4.20%+51.38%+21.75%-20.61%-41.51%-38.19%-11.25%--0.45%LossLoss3.60%Biotechnology

VKTXViking Therapeutics

25.2600.270+1.08%2.13M53.75M25.11024.99026.42024.3402.84B2.78B112.31M109.88M+6.49%+13.68%-1.52%-25.02%-65.18%-66.01%-37.23%--1.94%LossLoss8.32%Biotechnology

PFEPfizer

23.0150.095+0.41%34.32M792.67M23.05022.92023.29022.900130.43B130.23B5.67B5.66B+4.42%+5.04%-8.71%-14.47%-16.05%-3.71%-11.81%7.30%0.61%16.3216.321.70%Drug Manufacturers - General

NVONovo-Nordisk A/S

62.2280.148+0.24%4.47M279.75M62.17062.08063.24662.150276.33B198.50B4.44B3.19B+6.68%-3.87%-8.70%-25.86%-43.48%-49.93%-26.45%2.21%0.14%18.0718.071.77%Drug Manufacturers - General

AMGNAmgen

281.1410.301+0.11%803.98K226.94M280.630280.840284.060280.000151.03B150.65B537.20M535.84M+2.73%-1.69%-8.41%-0.21%-10.77%+7.31%+8.74%3.20%0.15%37.1937.191.45%Drug Manufacturers - General

ALTAltimmune

5.015-0.055-1.08%1.14M5.77M5.0805.0705.2304.930386.22M382.82M77.01M76.34M+4.70%+13.72%-5.73%-28.36%-25.59%-30.92%-30.44%--1.50%LossLoss5.92%Biotechnology

LLYEli Lilly and Co

870.780-13.760-1.56%2.45M2.14B869.780884.540882.250864.410825.49B823.55B947.99M945.76M+6.45%+18.89%+5.87%+5.96%+5.30%+19.49%+12.99%0.60%0.26%74.3674.362.02%Drug Manufacturers - General

News

Comments

105754083

9 hours ago

$Pfizer (PFE.US)$ what will the financial result gonna be today?

Moo Options Explorer

9 hours ago

Weekly roundup: Market shifts, tariff optimism, and earnings results

Hello mooers!
It’s been an eventful week in the markets, with a dramatic shift in sentiment from Monday’s bearish close to a four-day rally starting Tuesday. This change resulted from improving tariff dynamics and slightly better-than-expected earnings reports. As a result, $NASDAQ 100 Index (.NDX.US)$ surged 6.43% for the week, $S&P 500 Index (.SPX.US)$ rose 4.59%, and $Russell 2000 Index (.RUT.US)$ gained 4.09%, reflecting str...

+28

Teddy123

15 hours ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

$Pfizer (PFE.US)$
Breakthrough: Pfizer's New Bladder Cancer Treatment First Major Advance in 30 Years - See 91% Success Rate

Deep Sea

16 hours ago

$Pfizer (PFE.US)$
Pfizer (PFE) announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody, in combination with standard of care Bacillus Calmette-Guerin as induction therapy with or without maintenance in patients with BCG-naive, high-risk non-muscle invasive bladder cancer, NMIBC. The trial met its primary endpoint of event-free survival, EFS, by investigator assessment, demonstrating a clinically meaningful and statistically significan...

搞经济抄底加仓

Apr 27 06:31

I'm just thinking if FDA, WHO, and them are together in this.. ? whatever cancer cure and other cure forever stop at 50% to 85% and they will change to another new treatment and then 50% to 85% and repeat.. seriously, is 2025 already they think we're still living in 1925 when all people don't go to school?
get done once, just once a 100%
$Johnson & Johnson (JNJ.US)$
$Pfizer (PFE.US)$
$E-mini NASDAQ 100 Futures(JUN5) (NQmain.US)$
$E-mini S&P 500 Futures(JUN5) (ESmain.US)$